Cargando…
Clinical factors predicting drug-induced liver injury due to flucloxacillin
OBJECTIVES: Drug-induced liver injury (DILI) is a serious adverse reaction due to flucloxacillin. The pathogenesis is not fully understood. Female sex, age over 60 years, and a longer treatment duration have been suggested to be predisposing factors. Carriers of HLA-B*57:01 have an 80-fold increased...
Autores principales: | Lindh, Mikaela, Hallberg, Pär, Yue, Qun-Ying, Wadelius, Mia |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6254585/ https://www.ncbi.nlm.nih.gov/pubmed/30538582 http://dx.doi.org/10.2147/DHPS.S178394 |
Ejemplares similares
-
Identification of flucloxacillin-modified hepatocellular proteins: implications in flucloxacillin-induced liver injury
por: Ali, Serat-E, et al.
Publicado: (2023) -
Fusidic Acid: A Neglected Risk Factor for Statin-Associated Myopathy
por: Rönnqvist, Josefine, et al.
Publicado: (2018) -
SWEDEGENE—a Swedish nation-wide DNA sample collection for pharmacogenomic studies of serious adverse drug reactions
por: Hallberg, Pär, et al.
Publicado: (2020) -
Bile Nephropathy in Flucloxacillin-Induced Cholestatic Liver Dysfunction
por: Alnasrallah, Basil, et al.
Publicado: (2016) -
Role of Kupffer cells in liver injury induced by CpG oligodeoxynucleotide and flucloxacillin in mice
por: Gao, Yuying, et al.
Publicado: (2020)